Skip to main content Accessibility help

Cost-effectiveness of mandatory folate fortification v. other options for the prevention of neural tube defects: results from Australia and New Zealand

  • Kim Dalziel (a1), Leonie Segal (a1) and Rachelle Katz (a1)



To provide input to Australian and New Zealand government decision making regarding an optimal strategy to reduce the rate of neural tube defects (NTD).


Standard comparative health economic evaluation techniques were employed for a set of intervention options for promoting folate/folic acid consumption in women capable of or planning a pregnancy. Evidence of effectiveness was informed by the international literature and costs were derived for Australia and New Zealand.


Population-wide campaigns to promote supplement use and mandatory fortification were the most effective at reducing NTD, at an estimated 36 and 31 fewer cases per annum respectively for Australia and New Zealand, representing an 8 % reduction in the current annual NTD rate. Population-wide and targeted approaches to increase supplement use were cost-effective, at less than $AU 12 500 per disability-adjusted life year (DALY) averted ($US 9893, £5074), as was extending voluntary fortification. Mandatory fortification was not cost-effective for New Zealand at $AU 138 500 per DALY ($US 109 609, £56 216), with results uncertain for Australia, given widely varying cost estimates. Promoting a folate-rich diet was least cost-effective, with benefits restricted to impact on NTD.


Several options for reducing NTD appear to fall well within accepted societal cost-effectiveness norms. All estimates are subject to considerable uncertainty, exacerbated by possible interactions between interventions, including impacts on currently effective strategies. The Australian and New Zealand governments have decided to proceed with mandatory fortification; it is hoped they will support a rigorous evaluation which will contribute to the evidence base.

    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Cost-effectiveness of mandatory folate fortification v. other options for the prevention of neural tube defects: results from Australia and New Zealand
      Available formats

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Cost-effectiveness of mandatory folate fortification v. other options for the prevention of neural tube defects: results from Australia and New Zealand
      Available formats

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Cost-effectiveness of mandatory folate fortification v. other options for the prevention of neural tube defects: results from Australia and New Zealand
      Available formats


Corresponding author

*Corresponding author: Email


Hide All
1.Lumley, J, Watson, L, Watson, M & Bower, C (2001) Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev issue 3, CD001056.
2.European Surveillance of Congenital Anomalies (2005) Special Report: Prevention of Neural Tube Defects by Perioconceptional Folic Acid Supplementation in Europe. Northern Ireland: Eurocat.
3.Lancaster, P & Hurst, T (2001) Trends in Neural Tube Defects in Australia. Canberra: AIHW National Perinatal Statistics Unit, University of New South Wales, Australian Food and Nutrition Monitoring Unit.
4.Bower, C, DeKlerk, N, Hickling, S, Ambrosini, G, Flicker, L, Geelhoed, E & Milne, E (2006) Assessment of the potential effect of incremental increases on folic acid intake on neural tube defects in Australia and New Zealand. Aust N Z J Public Health 30, 369374.
5.Department of Health (1992) Folic Acid and the Prevention of Neural Tube Defects. Report from an Expert Advisory Group. London: HMSO.
6.Institute of Medicine, Food and Nutrition Board (1998) Dietary Reference Intakes: Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academy Press.
7.Australian Government, Department of Health and Ageing, National Health and Medical Research Council & New Zealand Ministry of Health (2006) Nutrient Reference Values for Australia and New Zealand Including Recommended Dietary Intakes. Canberra: Commonwealth of Australia.
8.Conlin, ML, MacLennan, AH & Broadbent, JL (2006) Inadequate compliance with periconceptional folic acid supplementation in South Australia. Aust N Z J Obstet Gynaecol 46, 528533.
9.Segal, L, Dalziel, K& Katz, R (2007). A Report to FSANZ. Informing a Strategy for Increasing Folate Levels to Prevent Neural Tube Defects: A Cost-effectiveness Analysis of Options. (accessed August 2009).
10.Bower, C, Ryan, A, Rudy, E & Miller, M (2002) Trends in neural tube defects in Western Australia. Aust N Z J Public Health 26, 150151.
11.Food Standards Australia and New Zealand (2006) Final Assessment Report. Proposal P295. Consideration of Mandatory Fortification with Folic Acid. Canberra: FSANZ.
12.Australian Bureau of Statistics (1998) National Nutrition Survey: Nutrient Intakes and Physical Measurements. Australia, 1995. ABS Catalogue no. 4805.0. Canberra: ABS.
13.New Zealand Ministry of Health (1999) NZ Food: NZ People – Key Results of the 1997 National Nutrition Survey. Wellington: NZMoH.
14.Bower, C, Blum, L, O’Daly, K, Higgins, C, Loutsky, F & Kosky, C (1997) Promotion of folate for the prevention of neural tube defects: knowledge and use of periconceptional folic acid supplements in Western Australia, 1992 to 1995. Aust N Z J Public Health 21, 716721.
15.Centre for Reviews and Dissemination (2001) Undertaking Systematic Reviews of Research on Effectiveness: CRD’s Guidance for Those Carrying Out or Commissioning Reviews. CRD Report no. 4, 2nd ed. York: University of York.
16.Austral ian Government, Department of Health and Ageing (2006) Medicare Benefits Schedule Book. Canberra: Commonwealth of Australia.
17.Carter, R & Scollo, M (2000) Economic evaluation of the National Tobacco Campaign. In Australia’s National Tobacco Campaign: Evaluation Report. vol. 2: Every Cigarette Is Doing You Damage, pp. 201244 [K Hassard, editor]. Canberra: Commonwealth Department of Health and Ageing.
18.Australian Government (2005) Skin cancer awareness. Budget (2005–2006), Health Fact Sheet 1 – Investing in Australia’s health: Strengthening Cancer Care. (accessed March 2007).
19.Australian Government (2005) Go for 2&5 campaign. (accessed March 2007).
20.Cameron, M, Haworth, N, Oxley, J, Newstead, S & Le, T (1993) Evaluation of Transport Accident Commission Road Safety Television Advertising. MUARC Report no. 52. Victoria: Monash University Accident Research Centre.
21.Rapley, M (2003) QoL in health and social care. In Quality of Life Research: A Critical Introduction, Ist ed., pp. 139165. London: Sage Publications.
22.Stouthard, MEA, Essink-Bot, M-L & Bonsel, GJ, on behalf of the Dutch Disability Weights Group (2000) Disability weights for diseases: a modified protocol and results for a Western European region. Eur J Public Health 10, 2430.
23.Department of Human Services, Public Health Division (1999) Victorian Burden of Disease Study: Morbidity. Melbourne: Department of Human Services.
24.Access Economics (2006) Cost benefit analysis of fortifying the food supply with folic acid. In Final Assessment Report. Proposal P295. Consideration of Mandatory Fortification with Folic Acid, pp. 2021, attachment 11b. Canberra: FSANZ.
25.Australian Bureau of Statistics (2006) Population by Age and Sex, Australian States and Territories. ABS Catalogue no. 3201.0. Canberra: ABS.
26.Rowland, CA, Correa, A, Cragan, JD & Alverson, CJ (2006) Are encephaloceles neural tube defects? Pediatrics 118, 916923.
27.George, B, Harris, A & Mitchell, A (2001) Cost-effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in Australia (1991 to 1996). Pharmacoeconomics 19, 18.
28.Busby, A, Abramsky, L, Dolk, H & Armstrong, BA (2005) Eurocat Folic Acid Working Group. Preventing neural tube defects in Europe: population based study. BMJ 330, 574575.
29.Centers for Disease Control and Prevention (2008) Use of supplements containing folic acid among women of childbearing age – United States, 2007. MMWR Morb Mortal Wkly Rep 57, 58.
30.Lawrence, JM, Watkins, ML, Chiu, V, Erikson, JD & Petitti, DB (2006) Do racial and ethnic differences in serum folate values exist after food fortification with folic acid? Am J Obstet Gynecol 194, 520526.
31.Centers for Disease Control and Prevention (2008) Treated in wheat-flour fortification with folic acid and iron – worldwide, 2004 and 2007. MMWR Morb Mortal Wkly Rep 57, 810.
32.Choumenkovitch, SF, Selhub, J, Wilson, PWF, Rader, JI, Rosenberg, IH & Jacques, PF (2002) Folic acid intake from fortification in the United States exceeds predictions. J Nutr 132, 27922798.
33.Centers for Disease Control and Prevention (2004) Spina bifida and anencephaly before and after folic acid mandate – United States, 1995–1996 and 1999–2000. MMWR Morb Moral Wkly Rep 53, 362365.
34.Grosse, SD, Waitzman, NJ, Romano, PS & Mulinare, J (2005) Reevaluating the benefits of folic acid fortification in the United States: economic analysis, regulation and public health. Am J Public Health 95, 19171922.
35.Pfeiffer, CM, Johnson, CL, Jain, RB, Yetley, EA, Picciano, MF, Rader, JI, Fisher, KD, Mulinare, J & Osterloh, JD (2007) Trends in blood folate and vitamin B-12 concentrations in the United States, 1988–2004. Am J Clin Nutr 86, 718721.
36.De Wals, P, Tairou, F, Van Allen, MI et al. (2007) Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med 357, 135142.
37.Lopez-Camelo, JS, Orioli, IM, da Graca Dutra, M et al. (2005) Reduction of birth prevalence rates of neural tube defects after folic acid fortification in Chile. Am J Med Genet A 135, 120125.
38.Chen, LT & Rivera, MA (2004) The Costa Rican experience: reduction in neural tube defects following food fortification programs. Nutr Rev 62, 6 Pt 2, S40S43.
39.Safdar, OY, Al-Dabbagh, AA, Abueliieneen, WA & Kari, JA (2007) Decline in incidence of neural tube defects after the national fortification of flour (1997–2005). Saudi Med J 28, 12271229.
40.Daly, LE, Kirke, PN, Molloy, A, Weir, DG & Scott, JM (2005) Folate levels and neural tube defects: implications for prevention. JAMA 274, 16981702.
41.Dietrich, M, Brown, CJP & Block, G (2005) The effect of folate fortification of cereal-grain products on blood folate status, dietary folate intake, and dietary folate sources among adult non-supplement users in the United States. J Am Coll Nutr 24, 266274.
42.Llanos, A, Hertrampf, E, Cortes, F, Pardo, A, Grosse, SD & Uauy, R (2007) Cost-effectiveness of a folic acid fortification program in Chile. Health Policy 83, 295303.
43.Jentik, J, can de Vrie-Hoekstra, NW, de Jong-van den Berg, LT & Postma, MJ (2008) Economic evaluation of folic acid food fortification in The Netherlands. Eur J Public Health 18, 270274.
44.Romano, PS, Waitzman, NJ, Scheffler, RM & Pi, RD (1995) Folic acid fortification of grain: an economic analysis. Am J Public Health 85, 667676.
45.Postma, MJ, Londeman, J, Veenstra, M, de Walle, HEK & de Jong- van den Berg, LTW (2002) Cost effectiveness of periconceptional supplementation of folic acid. PharmWorld Sci 24, 811.
46.Fenech, M, Noakes, M, Clifton, P & Topping, D (1999) Aleurone flour is a rich source of bioavailable folate in humans. J Nutr 129, 11141119.
47.Tice, JA, Ross, E, Coxson, PG, Rosenberg, I, Weinstein, MC, Hunick, MG, Goldman, PA, Williams, L & Goldman, L (2001) Cost effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease: effect of grain fortification and beyond. JAMA 286, 936943.
48.Hutubessy, R, Chisholm, D, Tan-Torres Edejer, T & WHO-CHOICE (2003) Generalized cost-effectiveness analysis for national-level priority-setting in the health sector. Cost Eff Resour Alloc 1, 113.
49.Murray, CJL, Evans, DB, Acharya, A & Baltussen, RMPM (2000) Development of the WHO guidelines on generalized cost-effectiveness analysis. Health Econ 9, 235251.
50.Marsack, CR, Alsop, CL, Kurinczuk, JJ & Bower, C (1995) Pre-pregnancy counselling for the primary prevention of birth defects: rubella vaccination and folate intake. Med J Aust 162, 403406.
51.Chacko, MR, Anding, R, Kozinetz, CA, Grover, JL & Smith, PB (2003) Neural tube defects: knowledge and preconceptional prevention practices in minority young women. Pediatrics 112, 536542.
52.Robbins, JM, Cleves, MA, Collins, HB, Andrews, N, Smith, LN & Hobbs, CA (2005) Randomized trial of a physician-based intervention to increase the use of folic acid supplements among women. Am J Obstet Gynecol 192, 11261132.
53.Ashfield-Watt, PAL, Whiting, JM, Clark, ZE, Moat, SJ, Newcombe, RG, Burr, ML & McDowell, IFW (2003) A comparison of the effect of advice to eat either ‘5-a-day’ fruit and vegetables or folic acid-fortified foods on plasma folate and homocysteine. Eur J Clin Nutr 57, 316323.
54.Woolcott Research (2006) Research Report: Evaluation of the National Go For 2&5 Campaign. New South Wales: Woolcott Research. Walle, HEK, van der Pal, KM, de Jong-van den Berg, LTW, Jeeninga, W, Schouten, JSAG, de Rover, CM, Buitendijk, SE & Cornel, MC (1999) Effect of mass media campaign to reduce socioeconomic differences in women’s awareness and behaviour concerning use of folic acid: cross sectional study. BMJ 319, 291292.



Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed